Stock research
Danaher Corporation DHR
- Ticker
- DHR
- Exchange
- NYSE
- Sector
- Health
- Founded
- 1969
What moves DHR
Danaher Corporation sits in Health Care. Pharmaceuticals, biotech, medical devices, and managed care — defensive demand paired with binary drug and regulatory catalysts. The forces that matter most for the sector — and therefore for DHR — are:
- ◆Drug approvals and clinical-trial readouts
- ◆Medicare and drug-pricing policy
- ◆Demographics and an aging population
- ◆GLP-1 and obesity-drug demand
Congressional trading in DHR
From time to time, Danaher Corporation shows up in the stock transactions members of Congress disclose under the STOCK Act. On its own that's just data — Yield Theory's job is to tell you whether it means anything.
We track these disclosures and read them as one input into the bigger picture: who is positioning, why, and what it implies for capital flows. See the congressional trades tracker for the lawmakers whose filings we watch most closely.
Lawmakers active in Health Care
How Yield Theory covers DHR
DHR intersects several of the themes in every Yield Theory issue. We don't chase headlines on individual tickers — we track where capital is rotating and explain what it means for the names in its path.
More Health Care stocks
DHR — frequently asked questions
What sector is DHR in?
Danaher Corporation is classified in the Health Care sector and trades on the NYSE.
Do members of Congress trade DHR?
Congressional trading in DHR appears in public STOCK Act disclosures from time to time. Yield Theory folds notable political flows into its broader analysis.
Is DHR a good investment?
We don't publish one-line buy/sell ratings. Yield Theory members get the full macro thesis, catalysts, and risks behind every name we cover, so you can decide with conviction. This page is research, not investment advice.
Where is Danaher Corporation headquartered?
Danaher Corporation is headquartered in Washington, District of Columbia and was founded in 1969.
This page is independent research and educational information, not investment advice or a recommendation to buy or sell any security. Company facts are compiled from public sources. Do your own research.
Want the full thesis on DHR?
Yield Theory members get macro-driven research and stock recommendations every month — with the catalysts and risks spelled out. Founding price $24.99/mo.
$24.99/mo · cancel anytime · researched by humans